# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001140361-25-019977
Filing Date
2025-05-21
Accepted
2025-05-21 07:00:41
Documents
7
Period of Report
2025-05-21

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 6-K | ef20049433_6k.htm | 6-K | 11960
2 | EXHIBIT 99.1 | ef20049433_ex99-1.htm | EX-99.1 | 26194
3 | EXHIBIT 99.2 | ef20049433_ex99-2.htm | EX-99.2 | 18602
4 | EXHIBIT 99.3 | ef20049433_ex99-3.htm | EX-99.3 | 13884
5 | GRAPHIC | ef20049433_ex99-1slide1.jpg | GRAPHIC | 817306
6 | GRAPHIC | ef20049433_ex99-2slide1.jpg | GRAPHIC | 682943
7 | GRAPHIC | ef20049433_ex99-3slide1.jpg | GRAPHIC | 558208
| Complete submission text file | 0001140361-25-019977.txt |  | 2906907

Mailing Address JOSHUA DAWSON HOUSE DAWSON STREET DUBLIN 2 L2 D02 RY95
Business Address JOSHUA DAWSON HOUSE DAWSON STREET DUBLIN 2 L2 D02 RY95 353 1 437 8334
GH Research PLC (Filer) CIK: 0001855129 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-40530 | Film No.: 25970873
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)